Cargando…

Genetic diversity within leukemia-associated immunophenotype-defined subclones in AML

Acute myeloid leukemia (AML) is a highly heterogeneous disease showing dynamic clonal evolution patterns over time. Various subclones may be present simultaneously and subclones may show a different expansion pattern and respond differently to applied therapies. It is already clear that immunophenot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tiso, F., Koorenhof-Scheele, T. N., Huys, E., Martens, J. H. A., de Graaf, A. O., van der Reijden, B. A., Langemeijer, S. M. C., Preijers, F. W. M. B., Kroeze, L. I., Jansen, J. H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8810467/ https://www.ncbi.nlm.nih.gov/pubmed/35024892 http://dx.doi.org/10.1007/s00277-021-04747-x

Ejemplares similares

OMIP ‐ 081: A new 21‐monoclonal antibody 10‐color panel for diagnostic polychromatic immunophenotyping
por: Huys, Erik H. L. P. G., et al.
Publicado: (2021)

Defining consensus leukemia-associated immunophenotypes for detection of minimal residual disease in acute myeloid leukemia in a multicenter setting
por: Feller, N, et al.
Publicado: (2013)

Monocytosis and its association with clonal hematopoiesis in community-dwelling individuals
por: van Zeventer, Isabelle A., et al.
Publicado: (2022)

CombiFlow: Flow cytometry-based identification and characterization of genetically and functionally distinct AML subclones
por: Houtsma, Roos, et al.
Publicado: (2021)

Immunophenotypic characterisation of morphologically diagnosed cases of Acute Myeloid Leukaemia (AML)
por: Basharat, Maria, et al.
Publicado: (2019)

Purging human ovarian cortex of contaminating leukaemic cells by targeting the mitotic catastrophe signalling pathway
por: Eijkenboom, Lotte, et al.
Publicado: (2021)

TP53 mutated AML subclones exhibit engraftment in a humanized bone marrow ossicle mouse model
por: Pabst, Gabriel, et al.
Publicado: (2020)

Immunophenotyping beyond the limits of time
por: de Graaf, J. Fréderique, et al.
Publicado: (2023)

A recurrent pattern of chromosomal aberrations and immunophenotypic appearance defines anal squamous cell carcinomas.
por: Heselmeyer, K., et al.
Publicado: (1997)

Combating subclonal evolution of resistant cancer phenotypes
por: Brady, Samuel W., et al.
Publicado: (2017)

TP53 mutation defines a unique subgroup within complex karyotype de novo and therapy-related MDS/AML
por: Weinberg, Olga K., et al.
Publicado: (2022)

Inducible MLL-AF9 Expression Drives an AML Program during Human Pluripotent Stem Cell-Derived Hematopoietic Differentiation
por: Heuts, Branco M. H., et al.
Publicado: (2023)

Accurate Identification of Subclones in Tumor Genomes
por: Ahmadinejad, Navid, et al.
Publicado: (2022)

Ras/MAPK signalling intensity defines subclonal fitness in a mouse model of hepatocellular carcinoma
por: Lozano, Anthony, et al.
Publicado: (2023)

Distinct bone marrow immunophenotypic features define the splicing factor 3B subunit 1 (SF3B1)‐mutant myelodysplastic syndromes subtype
por: Duetz, Carolien, et al.
Publicado: (2021)

Clonal evolution in myelodysplastic syndromes
por: da Silva-Coelho, Pedro, et al.
Publicado: (2017)

Defining TCRγδ lymphoproliferative disorders by combined immunophenotypic and molecular evaluation
por: Teramo, Antonella, et al.
Publicado: (2022)

AML, NOS and AML-MRC as defined by multilineage dysplasia share a common mutation pattern which is distinct from AML-MRC as defined by MDS-related cytogenetics
por: Fuhrmann, Irene, et al.
Publicado: (2022)

Acute leukemias with unusual immunophenotypes.
por: Park, M. H., et al.
Publicado: (1992)

Publisher Correction: Combating subclonal evolution of resistant cancer phenotypes
por: Brady, Samuel W., et al.
Publicado: (2018)

Clonal Hematopoiesis Defined by Somatic Mutations Infrequently Co-occurs With Mosaic Loss of the Y Chromosome in a Population-based Cohort
por: Kamphuis, Priscilla, et al.
Publicado: (2023)

Clinical impact of the subclonal architecture and mutational complexity in chronic lymphocytic leukemia
por: Nadeu, F, et al.
Publicado: (2018)

The evolution of lung cancer and impact of subclonal selection in TRACERx
por: Frankell, Alexander M., et al.
Publicado: (2023)

Apoptosis-Related Gene Expression Profiling in Hematopoietic Cell Fractions of MDS Patients
por: Langemeijer, Saskia MC, et al.
Publicado: (2016)

Immunophenotype
por: Albani, Salvatore
Publicado: (2014)

Subclonal heterogeneity and evolution in breast cancer
por: Mavrommati, Ioanna, et al.
Publicado: (2021)

Hierarchical cluster analysis of immunophenotype classify AML patients with NPM1 gene mutation into two groups with distinct prognosis
por: Chen, Chien-Yuan, et al.
Publicado: (2013)

Single cell proteogenomic sequencing identifies a relapse‐fated AML subclone carrying FLT3‐ITD with CN‐LOH at chr13q
por: Kim, TaeHyung, et al.
Publicado: (2022)

Chromatin-Based Classification of Genetically Heterogeneous AMLs into Two Distinct Subtypes with Diverse Stemness Phenotypes
por: Yi, Guoqiang, et al.
Publicado: (2019)

Quantifying Clonal and Subclonal Passenger Mutations in Cancer Evolution
por: Bozic, Ivana, et al.
Publicado: (2016)

Standardizing Flow Cytometry Immunophenotyping Analysis from the Human ImmunoPhenotyping Consortium
por: Finak, Greg, et al.
Publicado: (2016)

Molecular Characterization of Differentiated-Resistance MSC Subclones by Single-Cell Transcriptomes
por: Stucky, Andres, et al.
Publicado: (2022)

Benchmarking pipelines for subclonal deconvolution of bulk tumour sequencing data
por: Tanner, Georgette, et al.
Publicado: (2021)

Extensive subclonal mutational diversity in human colorectal cancer and its significance
por: Loeb, Lawrence A., et al.
Publicado: (2019)

Relapse-Fated Subclones: Finding the Needle in the Haystack
por: Tesio, Melania
Publicado: (2020)

Exploring the Eco-Evolutionary Dynamics of Tumor Subclones
por: Rampias, Theodoros
Publicado: (2020)

Genome-wide co-occupancy of AML1-ETO and N-CoR defines the t(8;21) AML signature in leukemic cells
por: Trombly, Daniel J, et al.
Publicado: (2015)

Tracking the origins and drivers of subclonal metastatic expansion in prostate cancer
por: Hong, Matthew K.H., et al.
Publicado: (2015)

Subclonal Somatic Copy-Number Alterations Emerge and Dominate in Recurrent Osteosarcoma
por: Kinnaman, Michael D., et al.
Publicado: (2023)

Leukocyte immunophenotyping: methodological aspects
por: Jämsä, J, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_3sb5mi4hp1vh4b1vlt9m2h1v57